Aura Biosciences, Inc. (AURA) Ownership

$6.05

north_east
$0.03 (0.5%)
Day's range
$6
Day's range
$6.28

Aura Biosciences, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MATRIX CAPITAL MANAGEMENT COMPANY, LP 11/13/2025 6.92 M $42.78 M   0.00% 11.93%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 11/14/2025 5.10 M $31.52 M   0.00% 8.79%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 4.88 M $30.17 M   0.00% 8.41%
LONG FOCUS CAPITAL MANAGEMENT, LLC 11/14/2025 4.62 M $28.55 M   0.00% 7.96%
SUVRETTA CAPITAL MANAGEMENT, LLC 11/14/2025 4.37 M $27.02 M   0.00% 7.54%
BLACKROCK, INC. 11/12/2025 3.41 M $21.05 M   9.76% 5.87%
MEDICXI VENTURES MANAGEMENT (JERSEY) LTD 10/17/2025 3.04 M $18.79 M   0.00% 5.24%
VANGUARD GROUP INC 11/07/2025 2.89 M $17.86 M   16.67% 4.98%
FRANKLIN RESOURCES INC 11/13/2025 2.20 M $13.59 M   -6.06% 3.79%
NANTAHALA CAPITAL MANAGEMENT, LLC 11/14/2025 2.12 M $13.09 M   0.00% 3.65%
LEVIN CAPITAL STRATEGIES, L.P. 11/07/2025 1.63 M $10.06 M   8.81% 2.80%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 1.26 M $7.78 M   35.27% 2.17%
UBS GROUP AG 11/13/2025 896.81 K $5.54 M   0.65% 1.55%
STATE STREET CORP 11/14/2025 878.87 K $5.43 M   2.65% 1.51%
REGENCY CAPITAL MANAGEMENT INC.\DE 10/21/2025 612.69 K $3.79 M   -7.99% 1.06%
ACORN CAPITAL ADVISORS, LLC 11/17/2025 595.74 K $3.68 M   0.00% 1.03%
SAMSARA BIOCAPITAL, LLC 11/14/2025 584.85 K $3.61 M   -41.52% 1.01%
B GROUP, INC. 11/14/2025 572.58 K $3.54 M   0.00% 0.99%
DECHENG CAPITAL LLC 11/14/2025 515.56 K $3.19 M   0.00% 0.89%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 497.28 K $3.07 M   9.01% 0.86%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2025 481.23 K $2.98 M   -4.67% 0.83%
NORTHERN TRUST CORP 11/14/2025 433.64 K $2.68 M   17.05% 0.75%
CALIGAN PARTNERS LP 11/14/2025 227.17 K $1.40 M   13.59% 0.39%
GOLDMAN SACHS GROUP INC 11/14/2025 194.94 K $1.20 M   -8.17% 0.34%
MILLENNIUM MANAGEMENT LLC 11/14/2025 185.22 K $1.14 M   49.30% 0.32%
MORGAN STANLEY 11/14/2025 178.51 K $1.10 M   18.78% 0.31%
PERMANENT CAPITAL MANAGEMENT, LP 10/17/2025 147.77 K $913.21 K   100.00% 0.25%
PLATINUM INVESTMENT MANAGEMENT LTD 11/13/2025 135.40 K $836.78 K   0.00% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 134.95 K $833.98 K   12.78% 0.23%
WELLINGTON MANAGEMENT GROUP LLP 11/14/2025 127.31 K $786.79 K   -32.81% 0.22%
AMERIPRISE FINANCIAL INC 11/14/2025 120.74 K $746.17 K   42.79% 0.21%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 97.61 K $603.22 K   -25.80% 0.17%
BANK OF NEW YORK MELLON CORP 11/03/2025 95.74 K $591.65 K   2.63% 0.17%
RESOLUTE CAPITAL ASSET PARTNERS LLC 11/14/2025 91.01 K $562.42 K   0.00% 0.16%
NUVEEN, LLC 11/12/2025 72.33 K $447.02 K   0.00% 0.12%
RHUMBLINE ADVISERS 11/06/2025 69.04 K $426.64 K   5.55% 0.12%
TD ASSET MANAGEMENT INC 11/10/2025 69.03 K $426.61 K   0.00% 0.12%
WALLEYE CAPITAL LLC 11/14/2025 67.30 K $415.89 K   100.00% 0.12%
BARCLAYS PLC 11/12/2025 64.93 K $401.28 K   -5.28% 0.11%
TBH GLOBAL ASSET MANAGEMENT, LLC 10/20/2025 60.32 K $372.79 K   0.00% 0.10%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 11/14/2025 59.66 K $368.69 K   -1.51% 0.10%
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC 11/14/2025 56.80 K $351.01 K   0.00% 0.10%
PRELUDE CAPITAL MANAGEMENT, LLC 11/14/2025 50.00 K $309.00 K   100.00% 0.09%
DEUTSCHE BANK AG\ 11/13/2025 45.46 K $280.91 K   100.00% 0.08%
QUANTINNO CAPITAL MANAGEMENT LP 11/14/2025 44.64 K $275.88 K   104.10% 0.08%
EXODUSPOINT CAPITAL MANAGEMENT, LP 11/14/2025 43.42 K $268.34 K   -0.30% 0.07%
ROYAL BANK OF CANADA 11/14/2025 42.54 K $263.00 K   10.10% 0.07%
ALLIANCEBERNSTEIN L.P. 11/14/2025 41.66 K $257.46 K   0.00% 0.07%
AMERICAN CENTURY COMPANIES INC 11/12/2025 38.69 K $239.12 K   -17.76% 0.07%
BANK OF AMERICA CORP /DE/ 11/14/2025 36.18 K $223.61 K   41.16% 0.06%

Aura Biosciences, Inc. institutional Ownership - FAQ's

During the previous two years, 122 institutional investors and hedge funds held shares of Aura Biosciences, Inc.. The most heavily invested institutionals were:

Matrix Capital Management Company, LP: 6.92 M

Frazier Life Sciences Management, L.P.: 5.1 M

ADAGE CAPITAL PARTNERS GP, L.L.C.: 4.88 M

Long Focus Capital Management, LLC: 4.62 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 4.37 M

BlackRock, Inc.: 3.41 M

89.03% of Aura Biosciences, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 55.92 M shares in the last 24 months. This purchase volume represents approximately $338.29 M in transactions.